NCT04782960

Subconjunctival Bupivacaine in Strabismus Surgery

The Effect of Subconjunctival Bupivacaine Injection in Squint Surgery for Postoperative Analgesia

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Fayoum University · Academic / Other
• Sex: All
• Age: 14 Years – 30 Years
• Healthy volunteers: Accepted

Summary

This study aimed to assess the effectiveness of the Subconjunctival bupivacaine on postoperative pain in Strabismus surgery under general anaesthesia.

Detailed description

40 patients will schedule for elective Strabismus surgery under general anaesthesia and randomly allocated into two groups to receive Subconjunctival 0.5%Bupivacaine group(B) or Subconjunctival placebo 0.9% normal saline group at the end of the surgery and assess the postoperative pain at 0th,30th, 60th,2nd h, 4h,6h,12h,24h.and post operative nausea and vomiting.

Conditions

• Anesthesia, Local

Interventions

Type	Name	Description
DRUG	Iocal anaesthetic bupivacaine	Local anaesthetic Subconjunctival bupivacaine
DRUG	Placebo	0.9 saline

Timeline

• Start date: 2021-04-01
• Primary completion: 2021-05-01
• Completion: 2021-05-01
• First posted: 2021-03-04
• Last updated: 2021-03-04